Abstract:Background: Experimental evidence suggests a key role of SIRT1 (silent information regulator 1) in age- and metabolic-related vascular dysfunction. Whether these effects hold true in the human microvasculature is unknown. We aimed to investigate the SIRT1 role in very early stages of age- and obesity-related microvascular dysfunction in humans. Methods: Ninety-five subjects undergoing elective laparoscopic surgery were recruited and stratified based on their body mass index status (above or below 30 kg/m2) and age (above or below 40 years) in 4 groups: Young Nonobese, Young Obese, Old Nonobese, and Old Obese. We measured small resistance arteries' endothelial function by pressurized micromyography before and after incubation with a SIRT1 agonist (SRT1720) and a mitochondria reactive oxygen species (mtROS) scavenger (MitoTEMPO). We assessed vascular levels of mtROS and nitric oxide availability by confocal microscopy and vascular gene expression of SIRT1 and mitochondrial proteins by qPCR. Chromatin immunoprecipitation assay was employed to investigate SIRT1-dependent epigenetic regulation of mitochondrial proteins. Results: Compared with Young Nonobese, obese and older patients showed lower vascular expression of SIRT1 and antioxidant proteins (FOXO3 [forkhead box protein O3] and SOD2) and higher expression of pro-oxidant and aging mitochondria proteins p66Shc and Arginase II. Old Obese, Young Obese and Old Nonobese groups endothelial dysfunction was rescued by SRT1720. The restoration was comparable to the one obtained with mitoTEMPO. These effects were explained by SIRT1-dependent chromatin changes leading to reduced p66Shc expression and upregulation of proteins involved in mitochondria respiratory chain. Conclusions: SIRT1 is a novel central modulator of the earliest microvascular damage induced by age and obesity. Through a complex epigenetic control mainly involving p66Shc and Arginase II, it influences mtROS levels, NO availability, and the expression of proteins of the mitochondria respiratory chain. Therapeutic modulation of SIRT1 restores obesity- and age-related endothelial dysfunction. Early targeting of SIRT1 might represent a crucial strategy to prevent age- and obesity-related microvascular dysfunction.

The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update

The Role of Sirtuin1 in Regulating Endothelial Function, Arterial Remodeling and Vascular Aging

From Microcirculation to Aging-Related Diseases: A Focus on Endothelial SIRT1

SIRT-Associated Attenuation of Cellular Senescence in Vascular Wall

The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis

Sirtuins family as a target in endothelial cell dysfunction: implications for vascular ageing

Sirt1 Inhibits Oxidative Stress in Vascular Endothelial Cells

The Role of Sirtuins and Uncoupling Proteins on Vascular Aging: The Northern Manhattan Study Experience

Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular Aging

Hypoxia-Inducible Factor-1α: The Master Regulator of Endothelial Cell Senescence in Vascular Aging

Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging

The role of sirtuin 1 in ageing and neurodegenerative disease: A molecular perspective

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Targeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels

The influential responsibility of sirtuins in senescence and associated diseases: A review

SIRT1‐mediated ERβ Suppression in the Endothelium Contributes to Vascular Aging

Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease

Targeting Mitochondrial Sirtuins in Age-Related Neurodegenerative Diseases and Fibrosis

Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation

Research progress of sirtuins in renal and cardiovascular diseases.

Regulation of SIRT1 in aging: Roles in mitochondrial function and biogenesis